Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Krompachy

5 clinical trials in Krompachy, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Krompachy at a glance
5
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Krompachy

Open in trial search

Study on ITI-1284 for Treating Agitation in Alzheimer's Patients

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:ITI-1284
  • Sponsor:Intra-Cellular Therapies Inc.

Psychotic disorder+2

Recruiting

Study on ITI-1284 for Treating Psychosis in Alzheimer's Patients

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:ITI-1284
  • Sponsor:Intra-Cellular Therapies Inc.

Migraine

Not recruiting

Study of IncobotulinumtoxinA injections compared to placebo for prevention of episodic migraine attacks

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
  • Sponsor:Merz Therapeutics GmbH

Migraine

Not recruiting

Study of incobotulinumtoxinA injections for prevention of chronic migraine in adult patients

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
  • Sponsor:Merz Therapeutics GmbH

Study on the Effects of Semaglutide in Patients with Early Alzheimer's Disease

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Other cities in Slovakia

The busiest research cities in the country

All 92 cities in Slovakia

Clinical research in Krompachy

What the registry says about research in the country

01 Neurodegenerative Disease Research

Groundbreaking clinical trials focusing on early Alzheimer's disease are exploring innovative therapeutic approaches. The research examines the potential of semaglutide in addressing cognitive decline in patients with mild cognitive impairment and mild dementia.

  • Cognitive Function Assessment
  • Disease Progression Monitoring
  • Standard of Care Enhancement

This long-term study aims to evaluate treatment effectiveness through detailed measurement of cognition and functional capabilities using the Clinical Dementia Rating Scale, representing a significant step forward in Alzheimer's research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.